InspireMD, Inc. NSPR
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -47.88% | 7.91% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -47.88% | 7.91% | |||
| Cost of Revenue | -6.12% | 37.68% | |||
| Gross Profit | -212.66% | -41.78% | |||
| SG&A Expenses | -5.31% | 1.15% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.68% | 14.07% | |||
| Operating Income | -3.34% | -15.67% | |||
| Income Before Tax | -4.64% | -17.02% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -4.64% | -16.39% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -4.64% | -16.39% | |||
| EBIT | -3.34% | -15.67% | |||
| EBITDA | -3.31% | -15.81% | |||
| EPS Basic | -3.61% | -14.36% | |||
| Normalized Basic EPS | -3.53% | -14.98% | |||
| EPS Diluted | -3.61% | -14.36% | |||
| Normalized Diluted EPS | -3.53% | -14.98% | |||
| Average Basic Shares Outstanding | 1.02% | 1.74% | |||
| Average Diluted Shares Outstanding | 1.02% | 1.74% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||